Novartis willing to sell Roche stake without demanding premium - CEO

ZURICH (Reuters) - Swiss drugmaker Novartis is ready to sell its near $14 billion stake in rival Roche without demanding a premium, Chief Executive Joe Jimenez said on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.